Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jagsonpal Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	15,497	14,422	7,313	7,592	8,214	2,085
Market Cap Growth	97.22%	97.22%	-3.68%	-7.58%	293.91%	353.56%
Enterprise Value	14,302	13,741	6,290	7,175	7,748	1,574
Last Close Price	232.95	217.20	109.31	113.28	122.57	30.19
PE Ratio	28.34	26.05	32.55	28.41	43.57	12.23
PS Ratio	5.77	5.37	3.50	3.21	3.78	1.11
PB Ratio	6.46	6.01	3.90	4.78	6.19	1.71
P/TBV Ratio	10.04	9.35	3.90	4.78	6.19	1.71
P/FCF Ratio	28.20	26.24	20.94	16.39	140.06	7.51
P/OCF Ratio	28.02	26.08	20.80	16.27	118.81	7.39
EV/Sales Ratio	5.32	5.11	3.01	3.03	3.56	0.84
EV/EBITDA Ratio	28.00	26.91	28.37	20.67	30.37	7.92
EV/EBIT Ratio	33.31	32.00	29.03	21.18	32.30	8.38
EV/FCF Ratio	26.03	25.01	18.01	15.49	132.10	5.67
Debt / Equity Ratio	0.04	0.04	0.05	0.04	-	0.06
Debt / EBITDA Ratio	0.18	0.18	0.38	0.17	-	0.34
Debt / FCF Ratio	0.17	0.17	0.26	0.13	-	0.25
Asset Turnover	1.09	1.09	1.01	1.32	1.33	1.20
Inventory Turnover	6.39	6.39	4.52	3.68	3.02	2.75
Quick Ratio	5.48	5.48	8.31	4.92	2.32	1.89
Current Ratio	6.22	6.22	10.42	5.97	4.04	2.98
Return on Equity (ROE)	25.91%	25.91%	12.97%	18.32%	14.81%	14.64%
Return on Assets (ROA)	10.84%	10.84%	6.57%	11.79%	9.13%	7.51%
Return on Capital (ROIC)	12.05%	12.05%	7.50%	14.23%	11.47%	9.54%
Return on Capital Employed (ROCE)	17.00%	17.00%	10.90%	20.20%	17.50%	15.20%
Earnings Yield	3.57%	3.84%	3.07%	3.52%	2.30%	8.18%
FCF Yield	3.55%	3.81%	4.78%	6.10%	0.71%	13.31%
Dividend Yield	1.06%	1.15%	1.83%	1.76%	1.31%	1.32%
Payout Ratio	23.90%	23.90%	58.31%	-	55.58%	15.36%
Buyback Yield / Dilution	-1.46%	-1.46%	-1.35%	-	-	-
Total Shareholder Return	-0.40%	-0.31%	0.48%	1.76%	1.31%	1.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.